From professional translators, enterprises, web pages and freely available translation repositories.
nelarabine
nelarabine
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
atriance nelarabine
atriance nelarabīns
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each vial contains 250 mg of nelarabine.
viens flakons satur 250 mg nelarabīna.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nelarabine is not diluted prior to administration.
nelarabīns pirms lietošanas netiek atšķaidīts.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
carcinogenicity testing of nelarabine has not been performed.
nelarabība kancerogenitāte nav testēta.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
atriance 5 mg/ml solution for infusion nelarabine
atriance 5 mg/ml šķīdums infūzijām nelarabine
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
neurotoxicity is the dose-limiting toxicity of nelarabine.
neirotoksicitāte ir nelarabīna devu ierobežojoša toksicitāte.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nelarabine has not been studied in individuals with renal impairment.
nelarabīns nav pētīts cilvēkiem ar nieru darbības traucējumiem.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
intracellular ara-gtp accumulated with repeated administration of nelarabine.
lietojot nelarabīnu atkārtoti, ara-gtf uzkrājās intracelulāri.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
the excretion of nelarabine in milk has not been studied in animals.
nelarabīna izdalīšanās pienā dzīvniekiem nav pētīta.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nelarabine should not be used during pregnancy unless clearly necessary.
nelarabīnu grūtniecības laikā nevajadzētu lietot, ja vien nav absolūta nepieciešamība.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
what atriance contains • the active substance of atriance is nelarabine.
ko atriance satur • atriance aktīvā viela ir nelarabīns.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
full recovery from these reactions has not always occurred with cessation of nelarabine.
pārtraucot nelarabīna lietošanu, šīs blakusparādības ne vienmēr pilnībā izzuda.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
patients with renal impairment must be closely monitored for toxicities when treated with nelarabine.
Ārstējot ar nelarabīnu, stingri jākontrolē, vai pacientiem ar nieru darbības traucējumiem nerodas toksiska ietekme.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the following adverse reactions have been identified during post-approval use of nelarabine.
pēcreģistrācijas periodā nelarabīna lietošanas laikā ir novērotas šādas blakusparādības.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
there have been reports of sometimes fatal opportunistic infections in patients receiving nelarabine therapy.
saņemti ziņojumi par dažreiz letālām oportūnistiskām infekcijām pacientiem, kas saņem nelarabīna terapiju.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nelarabine was mutagenic to l5178y/tk mouse lymphoma cells with and without metabolic activation.
nelarabīns bija mutagēns l5178y/tk peļu limfomas šūnām ar metabolisku aktivāciju un bez tās.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
neurotoxicity is the dose limiting toxicity associated with nelarabine therapy (see section 4.4).
neirotoksicitāte ir ar nelarabīna terapiju saistīta devu ierobežojoša toksicitāte (skatīt 4.4. apakšpunktu).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nelarabine however, is known to be genotoxic to mammalian cells (see section 5.3).
taču zināms, ka nelarabīns ir genotoksisks zīdītāju šūnām (skatīt 5.3. apakšpunktu).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
leukopenia, thrombocytopenia, anaemia, and neutropenia, (including febrile neutropenia) have been associated with nelarabine therapy.
saistībā ar nelarabīna lietošanu novērota leikopēnija, trombocitopēnija, anēmija un neitropēnija (arī febrila neitropēnija).
Last Update: 2017-04-26
Usage Frequency: 3
Quality: